BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18189140)

  • 1. Metachronous cancer development in patients with sporadic colorectal adenomas-multivariate risk model with independent and combined value of hTERT and survivin.
    Søreide K; Gudlaugsson E; Skaland I; Janssen EA; Van Diermen B; Körner H; Baak JP
    Int J Colorectal Dis; 2008 Apr; 23(4):389-400. PubMed ID: 18189140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-cycle and apoptosis regulators (p16INK4A, p21CIP1, beta-catenin, survivin, and hTERT) and morphometry-defined MPECs predict metachronous cancer development in colorectal adenoma patients.
    Soreide K; Buter TC; Janssen EA; Gudlaugsson E; Skaland I; Körner H; Baak JP
    Cell Oncol; 2007; 29(4):301-13. PubMed ID: 17641414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monotonous population of elongated cells (MPECs) in colorectal adenoma indicates a high risk of metachronous cancer.
    Soreide K; Buter TC; Janssen EA; van Diermen B; Baak JP
    Am J Surg Pathol; 2006 Sep; 30(9):1120-9. PubMed ID: 16931957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of small or diminutive adenomas at baseline colonoscopy on the risk of developing metachronous advanced colorectal neoplasia: KASID multicenter study.
    Moon CM; Jung SA; Eun CS; Park JJ; Seo GS; Cha JM; Park SC; Chun J; Lee HJ; Jung Y; Boo SJ; Kim JO; Joo YE; Park DI
    Dig Liver Dis; 2018 Aug; 50(8):847-852. PubMed ID: 29730157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of metachronous neoplasms in colorectal cancer patients: identification of risk factors.
    Ballesté B; Bessa X; Piñol V; Castellví-Bel S; Castells A; Alenda C; Paya A; Jover R; Xicola RM; Pons E; Llor X; Cordero C; Fernandez-Bañares F; de Castro L; Reñé JM; Andreu M;
    Dis Colon Rectum; 2007 Jul; 50(7):971-80. PubMed ID: 17468913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of the Management of Sporadic Colorectal Adenomas in Young People: Is Surveillance Wasted on the Young?
    Bushyhead D; Lin OST; Kozarek RA
    Dig Dis Sci; 2019 Aug; 64(8):2107-2112. PubMed ID: 30788685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and predictors of adenoma after surgery for colorectal cancer.
    Marques-Antunes J; Libânio D; Gonçalves P; Dinis-Ribeiro M; Pimentel-Nunes P
    Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):932-938. PubMed ID: 28682984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of colorectal neoplasia after polypectomy: based on initial and consecutive findings.
    van Enckevort CC; de Graaf AP; Hollema H; Sluiter WJ; Kleibeuker JH; Koornstra JJ
    Neth J Med; 2014 Apr; 72(3):139-45. PubMed ID: 24846927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Risk of Metachronous Advanced Colorectal Neoplasia Rises in Parallel with an Increasing Number of High-Risk Findings at Baseline.
    Lee SM; Kim JH; Sung IK; Hong SN
    Gut Liver; 2015 Nov; 9(6):741-9. PubMed ID: 25963078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of metachronous colorectal neoplasms in sporadic adenoma patients.
    Bertario L; Russo A; Sala P; Pizzetti P; Ballardini G; Andreola S; Spinelli P
    Int J Cancer; 2003 May; 105(1):82-7. PubMed ID: 12672034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced synchronous adenoma but not simple adenoma predicts the future development of metachronous neoplasia in patients with resected colorectal cancer.
    Moon CM; Cheon JH; Choi EH; Kim ES; Park JJ; Han SY; Kim DH; Kim TI; Kim WH
    J Clin Gastroenterol; 2010 Aug; 44(7):495-501. PubMed ID: 20351568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
    Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
    Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal adenoma stem-like cell populations: associations with adenoma characteristics and metachronous colorectal neoplasia.
    Bartley AN; Parikh N; Hsu CH; Roe DJ; Buckmeier JA; Corley L; Phipps RA; Gallick G; Lance P; Thompson PA; Hamilton SR
    Cancer Prev Res (Phila); 2013 Nov; 6(11):1162-70. PubMed ID: 24008128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the Risk of a Metachronous Advanced Colorectal Neoplasm Using a Novel Scoring System.
    Lee JY; Park HW; Kim MJ; Lee JS; Lee HS; Chang HS; Choe J; Hwang SW; Yang DH; Myung SJ; Yang SK; Byeon JS
    Dig Dis Sci; 2016 Oct; 61(10):3016-3025. PubMed ID: 27358228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human telomerase reverse transcriptase expression in colorectal tumors: correlations with immunohistochemical expression and clinicopathologic features.
    Simsek BC; Pehlivan S; Karaoglu A
    Ann Diagn Pathol; 2010 Dec; 14(6):413-7. PubMed ID: 21074689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia.
    Svec J; Musílková J; Bryndová J; Jirásek T; Mandys V; Kment M; Pácha J
    Inflamm Bowel Dis; 2010 Jul; 16(7):1127-37. PubMed ID: 20027603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the Sum of Adenoma Diameters (Adenoma Bulk) on Index Examination Predict Risk of Metachronous Advanced Neoplasia?
    Anderson JC; Morris CB; Robertson DJ; Barry ELR; Figueiredo JC; Cruz-Correa M; Bostick RM; Ahnen DJ; Baron JA
    J Clin Gastroenterol; 2018 Aug; 52(7):628-634. PubMed ID: 28767463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of human telomerase reverse transcriptase in vulvar intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study with survivin and p53.
    Wellenhofer A; Brustmann H
    Arch Pathol Lab Med; 2012 Nov; 136(11):1359-65. PubMed ID: 23106581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach.
    Ning Y; Hanna DL; Zhang W; Mendez A; Yang D; El-Khoueiry R; Matsusaka S; Sunakawa Y; Stremitzer S; Parekh A; Okazaki S; Berger MD; Barzi A; Lenz HJ
    Mol Cancer Ther; 2015 Oct; 14(10):2401-8. PubMed ID: 26227487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel risk stratification for recurrence after endoscopic resection of advanced colorectal adenoma.
    Seo JY; Chun J; Lee C; Hong KS; Im JP; Kim SG; Jung HC; Kim JS
    Gastrointest Endosc; 2015 Mar; 81(3):655-64. PubMed ID: 25500328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.